Search company, investor...

Symetis

symetis.com

Founded Year

2006

Stage

Acquired | Acquired

Total Raised

$56.6M

Valuation

$0000 

About Symetis

Symetis is a medical technology company specializing in the development, manufacturing and marketing of percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.

Headquarters Location

chemin de la venoge 11 Ecublens

Vaud, CH-1024,

Switzerland

+41 21 651 0160

Missing: Symetis's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Symetis's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Symetis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Symetis is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

8,560 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Symetis Patents

Symetis has filed 1 patent.

The 3 most popular patent topics include:

  • Cardiac surgery
  • Cardiac anatomy
  • Implants (medicine)
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/15/2020

9/27/2022

Cardiac surgery, Cardiac anatomy, Cardiology, Congenital heart defects, Valvular heart disease

Grant

Application Date

6/15/2020

Grant Date

9/27/2022

Title

Related Topics

Cardiac surgery, Cardiac anatomy, Cardiology, Congenital heart defects, Valvular heart disease

Status

Grant

Latest Symetis News

Global Heart Valve Repair and Replacement Market 2020 Top Companies – Edwards LifeSciences, Medtronic, Boston Scientific, Abbott Laboratories, St. Jude Medical, JenaValve Technology, SYMETIS

Aug 29, 2020

The Global Heart Valve Repair and Replacement Market report is collection of intelligent, comprehensive research studies that will help players and stakeholders to make informed business decisions in future. The report offers extensive research and analysis of key aspects of the global Heart Valve Repair and Replacement market. The report provides deeper understanding of the competitive landscape and its future scenarios, crucial dynamics, and leading segments of the global Heart Valve Repair and Replacement market. The report also provides accurate PESTLE, SWOT and other types of analysis on the global Heart Valve Repair and Replacement market. Moreover, the report offers highly accurate estimations on the CAGR, market share, and market size of key regions and countries. Players can use this study to explore untapped global Heart Valve Repair and Replacement markets to extend their reach and create sales opportunities. The report contains profiles of major companies/manufacturers operating in the global Heart Valve Repair and Replacement Market. Key Players Profiled in The Global Heart Valve Repair and Replacement MarketReport Include: : Edwards LifeSciences Highlights of The Global Heart Valve Repair and Replacement Market Report: • Detailed company profiling of top players of the global Heart Valve Repair and Replacement market. • Exhaustive research on innovation and other trends of the global Heart Valve Repair and Replacement market. • Identification and in-depth assessment of growth opportunities in key segments and regions. • Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects. • Accurate market size and CAGR forecasts for the period 2019-2027. • Reliable industry value chain and supply chain analysis. Global Heart Valve Repair and Replacement Market Split by Product Type and Applications: Global Heart Valve Repair and Replacement Market, On The basis of Type: Transcatheter Aortic Valve Replacement (TAVR) Transcatheter Mitral Valve Repair (TMVR) Global Heart Valve Repair and Replacement Market, On The basis of Application: Hospitals Cardiac Catheterization Laboratory The report has classified the global Heart Valve Repair and Replacement market into segments including product type and application. Every segment is estimated based on share and growth rate. Besides, the analysts have studied the potential regions that may prove rewarding for the Heart Valve Repair and Replacement manufacturers in the coming years. The regional analysis includes reliable forecasts on value and volume, thereby helping market players to gain deep insights into the overall Heart Valve Repair and Replacement industry. Regions Covered in The Global Heart Valve Repair and Replacement Market: The report also analyzed both developing and developed regions considered for the research and analysis of the global Heart Valve Repair and Replacement market. The regional analysis section of the report provides an extensive research study on different regional and country-wise Heart Valve Repair and Replacement industry to help players plan effective expansion strategies.The regional analysis includes reliable forecasts on value and volume, thereby helping market Region to gain deep insights into the overall Heart Valve Repair and Replacement industry. • The Middle East and Africa (GCC Countries and Egypt) • North America (the United States, Mexico, and Canada) • South America (Brazil etc.) • Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia) Do enquire to get a strategic overview of the market, Access Research Methodology Prepared By Experts at: https://www.innovateinsights.com/report/global-heart-valve-repair-and-replacement-market-by/65235/#buyinginquiry Global Heart Valve Repair and Replacement Market Study Objectives 2020   The report presents the main insights and for the period 2020-2027, the mobile phone turbo charger evaluates the total revenue generated in the market. However, the Heart Valve Repair and Replacement report provides both historical and approximate numbers (USD million) as value and enough CAGR. Many companies are associated with the Heart Valve Repair and Replacement business for a very long time, the scope of the global Heart Valve Repair and Replacement market will be wider in the future. Report Global Heart Valve Repair and Replacement provides SWOT analysis of active market participants so that you can try to move one step ahead of them. The Heart Valve Repair and Replacement Report places light on major market segments based on their individual performance in the global market. This detailed approach helps in understanding important Heart Valve Repair and Replacement market segments which are likely to dominate the industry over the coming years. Heart Valve Repair and Replacement report tracks the markets leading mobility, the study encompasses industry drivers and obstacles. The Heart Valve Repair and Replacement research report will enrich your decision-making capability by helping you to focus on technology trends   Take more informed business decisions by relying on the insightful opinions from Heart Valve Repair and Replacement industry experts   Design and improve your product development and sales strategies and enhancing your Heart Valve Repair and Replacement marketing activities   Create merger and acquisition opportunities by identifying the Heart Valve Repair and Replacement market players with the most innovative pipelines     Identify the regional Heart Valve Repair and Replacement market potential which would further help in designing regional market strategies     Develop business strategies by understanding the market dynamics and developments driving the Heart Valve Repair and Replacement Market The examination report on the global Heart Valve Repair and Replacement market offers a treasury of economic situations and strategies wherein the market has been acting in various circumstances. Additionally, this report covers the inside and out factual examination and the market elements and requests which give an entire situation of the business.

Symetis Frequently Asked Questions (FAQ)

  • When was Symetis founded?

    Symetis was founded in 2006.

  • Where is Symetis's headquarters?

    Symetis's headquarters is located at chemin de la venoge 11, Vaud.

  • What is Symetis's latest funding round?

    Symetis's latest funding round is Acquired.

  • How much did Symetis raise?

    Symetis raised a total of $56.6M.

  • Who are the investors of Symetis?

    Investors of Symetis include Boston Scientific, Truffle Capital, Novartis Venture Funds, Wellington Partners, Banexi Ventures and 9 more.

  • Who are Symetis's competitors?

    Competitors of Symetis include Clearflow, IlluminOss Medical, FloShield, VytronUS, Endovalve and 12 more.

Compare Symetis to Competitors

NeoChord Logo
NeoChord

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, is a beating heart procedure, echo-guided treatment for patients with mitral valve regurgitation and is proven to resolve and restore normal mitral valve function. The company was founded in 2007 and is based in Minneapolis, Minnesota.

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment.Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

C
Coromedic

Coromedic is a privately owned biomedical start up company working to manufacture devices and develop techniques to facilitate coronary artery bypass surgery in a minimally invasive technique. The company's flagship products, the proximal anastomosis device, the distal anastomosis device and the internal mammary artery harvester are a in a set of invaluable tools aimed at easing the complications associated with the conventional surgery. The company have worked to design and build prototypes of the company's products and develop a business strategy, consulting with numerous professionals to assess the feasibility and utility of the company's product and business model. The process of idea protection and patent application is ongoing, a provisional patent for one of the company's products, the proximal anastomosis devices is in place and the application for patent protection of all the company's products is underway. The prototype of the company's first device, the proximal anastomosis device is built and tested in the wet lab. The company are currently working on prototype assembly of the company's second and third products, after which lab animal experiments in the appropriate facilities will take place and then approval for clinical trials and their undertaking will commence.

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

Cardious Logo
Cardious

Cardious is a medical device company organized to develop and commercialize the AvA Aortic Valve Bypass Graft System for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy.

Endotronix Logo
Endotronix

Endotronix develops an integrated platform to provide reimbursable health management tools for patients suffering from chronic heart failure. The company's solution includes a cloud-based disease management data system and outpatient hemodynamic management with a wireless pulmonary artery sensor for early detection of worsening heart failure.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.